A treatment investigational new drug (tIND) program of tegaserod 6 mg bid [twice daily] given orally in women adult patients with irritable bowel syndrome with constipation or with chronic idiopathic constipation
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 23 Jan 2008
At a glance
- Drugs Tegaserod (Primary)
- Indications Constipation; Irritable bowel syndrome
- Focus Therapeutic Use
- Sponsors Novartis
- 23 Jan 2008 Added status according to nct updated 10 jan 08.
- 14 Aug 2007 New trial record.